Hvivo revenue falls as pharma market uncertainty hits
But the company remained on track to reach £47 million in revenue for the year, it said.
In a trading update for the six months ended June 30th 2025, the company said revenue for the period was £24.2 million, down from £35.6 million a year earlier.
Hvivo, which offers contract research to pharmaceutical companies, said in May that a significant contract for a human challenge trial had been cancelled, while another had been postponed. A smaller study had also been cancelled, the company said, blaming the uncertainty in the pharmaceutical sector and depressed financing for the biotech market.
READ MORE
Its weighted contracted order book was £40 million at the end of the first half, down from £71 million in the prior year.
However, the company said it had a strong sales pipeline, with opportunities that were not yet contracted and the aggregate value of customer proposals submitted in the first half of the year already surpassing the total in 2024. Its acquisitions of CRS and Cryostore, which were completed for £10.5 million net of cash acquired, are also diversifying its offerings. The acquisitions contributed £5.5 million to group revenue in the first half.
The group said it is in advance discussions for a number of major human challenge trial projectsand is also pursuing significant opportunities for its hLAB and clinical services operations.
'Some persistent macro and sector-specific headwinds remain however, including a subdued biotech funding environment partly connected to uncertainties in the US, which have impacted the broader CRO industry, resulting in delayed contract conversion and a number of cancellations and postponements,' Hvivo said in a statement.
It said the issues affecting the sector are likely to the 'transitory rather than fundamental', and predicted its business would return to growth as the market normalises, and biotech funding improves.
'The utility of our services remains strong, as demonstrated by the recent success of our client's Phase II candidate. Our diversification strategy is already delivering results, and we expect continued momentum across all revenue streams,' said chief executive Dr Yamin 'Mo' Khan.
'While macroeconomic and sector-specific headwinds are still affecting contract conversions, we remain confident in the long-term growth trajectory of our services and the overall prospects for HVIVO. I'm encouraged by the strength of our sales pipeline, with several major opportunities that could enhance the growth of our services. We believe that we are well positioned to deliver growth in FY26, and we look forward to keeping shareholders updated on our progress.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Irish Times
3 hours ago
- Irish Times
Betting tax increase in budget could raise €53m while higher vehicle levies also examined in tax strategy papers
Boosting betting tax in the budget would raise up to an extra €53 million a year for the State, according to Department of Finance officials. The tax take from betting almost doubled to €95 million in 2019 from €52 million the previous year, after the Government increased the rate on all bets placed in the State to 2 per cent from 1 per cent. Increasing the rate by 1 per cent would add a further €53 million a year, while adding 0.5 per cent would yield another €26.5 million, the department's Tax Strategy Group (TSG) report states. Government would collect a further €800,000 if it increased the tax on the commission earned by betting exchanges, which allow customers to bet against each other, to 30 per cent from 25 per cent, the report added. READ MORE But it cautions that those estimates depend on 'the betting market continuing as normal in 2025 and 2026″ with neither bookies nor their customers changing their behaviour. [ Income tax dilemma for Government as VAT cuts could cost €1bn Opens in new window ] 'It is understood the burden of such additional tax increases would mainly impact large bookmaking firms,' it said. Along with the increase in 2019, the Government introduced relief of €50,000, meant to ease the burden on small independent operators, whose share of the market has shrunk rapidly in recent years. The report suggests increasing this relief to €65,000 should the Government decide to boost the tax rate. However, it adds that Revenue officials argue that this would benefit only a handful of businesses, while it would add to the challenge of getting EU state aid approval for such a move. The report notes that three big businesses dominate the market. Although it does not name them, they are Irish-based giant, Flutter Entertainment, mostly through its subsidiary Paddy Power , Boylesports and UK-based Ladbrokes. A Health Research Report found in 2022 that problem gambling had fallen over the previous eight years, but still hit more than 135,000 lives in the Republic. Revenue figures show that betting is growing, but moving increasingly online. In 2019, customers wagered €28.9 million in cash and €23.5 million digitally, including €1.8 million with betting exchanges. In 2023, digital's share was more than €55 million, of a €102.7 million total, while punters bet €46.6 million in cash. Separately, a 1 per cent increase in the higher rates of Vehicle Registration Tax (VRT) is one of the budget options outlined by the TSG papers. It says that if applied across the upper VRT bands – 11 to 20 – covering the price of new and imported used cars, it 'would affect only cars with above-average emissions' and could raise €28 million based on 2024 registrations. The group also suggests increasing the NOx surcharge on new and imported cars by €5 per mg/km, potentially generating another €15.5 million. On Benefit-in-Kind tax (BIK), the paper proposes creating a new zero-emissions category, with rates ranging between 6 and 15 per cent, depending on annual business mileage. A higher VRT rate of 15 per cent is also suggested for vans and light commercial vehicles emitting more than 260g/km of CO2. This would sit above the recently introduced two-band emissions-based VRT system, where the top rate currently stands at 13.3 per cent for vehicles over 120g/km. The TSG notes that future reforms could include emissions-based BIK rates for vans, potentially retaining the current 8 per cent rate for low-emission models, with higher rates for those over a certain CO2 threshold. The latest TSG paper revises a proposal made last year on an additional VRT surcharge based on a vehicle's weight. Modelled on a system currently operated in France and Norway, an additional charge would be imposed on vehicles above a certain weight threshold, with various potential reliefs for the likes of fully-electric or hybrid models. The TSG states: 'It is well documented that the scale of the proposed electrification of the national fleet will entail significant revenue risk, with the growth in EVs expected to erode Exchequer receipts from motor tax, VRT, VAT and fuel excise, particularly if the current tax structures remain unchanged.' It estimates that revenue from taxes on fossil fuel use and related transport will fall by €1 billion by 2030, down from €5.3 billion in 2022.
Irish Times
4 hours ago
- Irish Times
Global markets soar amid signs of progress on US trade deals
Global markets soared on Thursday as investors digested US corporate earnings along with signs of progress in tariff negotiations between the US and its trading partners. Dublin Euronext Dublin was up 1.3 per cent, largely boosted by strong performances from the Irish banks. Bank of Ireland and AIB were up 4 per cent and 3 per cent respectively, with the banking sector generally up across Europe. Ryanair continued its recent rise, climbing 0.7 per cent. Its peer airline Wizz Air finished down 0.5 per cent after it missed first-quarter profit estimates. 'There was a bit activity around the airlines due to that news flow, and Ryanair benefited from that,' said a trader. READ MORE Elsewhere, two heavyweights on the index, food giant Kerry Group and Cavan-based insulation specialist Kingspan, both finished up 0.5 per cent. London Britain's FTSE 100 rose to a record close, boosted by upbeat corporate results and optimism over a potential EU-US trade agreement. The benchmark FTSE 100 closed up 0.9 per cent, while the domestically-oriented midcap FTSE 250 gained 0.6 per cent. The personal care and grocery stores index led sectoral gains, up 2.6 per cent, boosted by Reckitt, up 9.9 per cent, after the consumer goods company raised its annual revenue forecast. Healthcare stocks rose 1.9 per cent with AstraZeneca up 2.1 per cent after the drugmaker's rare immune disorder drug succeeded in an advanced trial. GSK added 1.4 per cent after the US Food and Drug Administration on Wednesday extended its review of the drugmaker's blood cancer drug. Media stocks advanced 2.3 per cent, led by ITV which rose 13.3 per cent after the broadcaster's half-year results beat forecasts. Conversely, precious metal miners fell 1.4 per cent, tracking a drop in gold prices. Endeavour Mining fell 1.3 per cent, and Fresnillo was down 2.1 per cent. Europe Shares on the Continent advanced amid reports the European Union and Washington were close to clinching a tariff agreement, close on the heels of a similar deal with Japan. MSCI's gauge of stocks across the globe rose 3.03 points. The pan-European Stoxx 600 index rose 0.23 per cent, while Europe's broad FTSEurofirst 300 index rose 0.2 per cent. The Dax 40 in Frankfurt gained 0.2 per cent, but the Cac 40 in Paris fell 0.4 per cent. New York The S&P 500 and the Nasdaq hit record highs as big technology stocks rose after Google parent Alphabet's robust earnings, while the Dow was weighed down by losses in IBM, UnitedHealth, and Honeywell. In morning trading, the S&P 500 gained 0.25 per cent; and the Nasdaq Composite gained 0.25 per cent. Alphabet rose 1.9 per cent after it raised its 2025 capital spending forecast, shrugging off trade jitters, and reinforcing investors' confidence in AI investments and returns. Losses in UnitedHealth, IBM and Honeywell weighed on the blue-chip Dow, which fell 0.33 per cent – though it remained close to its December 4th record high. UnitedHealth lost 3.7 per cent. The insurer revealed it's co-operating with a Department of Justice probe into its Medicare practices, following reports of both criminal and civil investigations. IBM dropped 8 per cent as its second-quarter results fell flat with investors, hampered by disappointing sales in its core software division. Honeywell, meanwhile, dipped 4.6 per cent despite topping Wall Street's expectations and raising its annual outlook. Electric vehicle maker Tesla tumbled 9 per cent, as CEO Elon Musk warned of 'a few rough quarters' due to cuts in EV incentives. The stock has fallen about 25 per cent for the year so far. Some of Wall Street's heavyweights were starting to feel the sting of Trump's sweeping tariffs. American Airlines fell 9.2 per cent after forecasting a bigger-than-expected third-quarter loss, hurt by sluggish domestic travel demand. – Additional reporting: Agencies
Irish Times
4 hours ago
- Irish Times
Profits rise at Cashel Blue producer with aims to fund further capital investment
Profits rose at Cashel Farmhouse Cheesemakers, the producer of the famous Cashel Blue cheese, with the company aiming to use the surplus to fund further capital investment. J & L Grubb Limited, the company behind the brand, recorded profit of more than €960,000 in the 2024 financial year, according to filings made to the Companies Registration Office. This followed a profit of €951,000 in 2023. A spokesman said the company was 'building reserves to allow continued investment' after it made a 'huge capital investment' in 2010. The Cashel Blue brand was created by Louis and Jane Grubb in 1984 and has continued to be made by hand on the same farmland since it was founded. It is based in Fethard, Co Tipperary. READ MORE The brand is now led by a new generation of the family: the founders' daughter and her husband, Sarah Furno and Sergio Furno. Speaking to The Irish Times, the spokesman said that 2023 was a 'particularly good year' with the company having benefited from a 'post-Covid bounce', which he said benefited the food sector generally. In 2024, however, a sharp increase in milk prices forced the company to 'change its pricing slightly' as farmers were hit by a wetter than expected start to the year, which disrupted dairy volumes and price. 'Every cost has gone up. You name it and everything has gone up,' the spokesman said, with the family business seeking to retain a 'simple philosophy' of trying to build the company sustainably in order to be able to 'make the next step.' 'We are a sustainable, family-based rural business trying to hire people from the locality. We use locally produced milk, and hire our labour locally as much as possible.' The majority of the business' sales are domestic, around 70 per cent, with the balance exported to other markets. While tariffs may impact the company's exports to the US, they only have a small portion of their exports exposed to that market. The market turmoil, however, has created 'opportunities' for the company as there is interest from new markets in their product as people are 'now shy of buying American', the spokesman said. Accumulated profits stood at €9.2 million, with more than €500,000 in finished goods in stock by the end of 2024. The company had 22 employees in 2024, down seven from the year prior.
